Cargando…

The Safety of Long-Term Proton Pump Inhibitor Use on Cardiovascular Health: A Meta-Analysis

Introduction: Proton pump inhibitors (PPIs) are one of the most prescribed classes of drugs worldwide as a first-line treatment of acid-related disorders. Although adverse effects are rare and rapidly reversible after a short exposure, concerns have been recently raised about a greater toxicity on c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeridi, Dalel, Pellat, Anna, Ginestet, Claire, Assaf, Antoine, Hallit, Rachel, Corre, Felix, Coriat, Romain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322047/ https://www.ncbi.nlm.nih.gov/pubmed/35887860 http://dx.doi.org/10.3390/jcm11144096

Ejemplares similares

Impact of Sarcopenia on Survival in Patients Treated with FOLFIRINOX in a First-Line Setting for Metastatic Pancreatic Carcinoma
por: Lellouche, Lisa, et al.
Publicado: (2023)

Therapeutic Management of Advanced Hepatocellular Carcinoma: An Updated Review
por: Falette Puisieux, Manon, et al.
Publicado: (2022)

A new system to prevent SARS-CoV-2 and microorganism air transmission through the air circulation system of endoscopes
por: Chaussade, Stanislas, et al.
Publicado: (2022)

Airborne transmission of SARS‐Cov2: What consequences for digestive endoscopy?
por: Chaussade, Stanislas, et al.
Publicado: (2023)

Well Differentiated Grade 3 Neuroendocrine Tumors of the Digestive Tract: A Narrative Review
por: Pellat, Anna, et al.
Publicado: (2020)

Updates on the Treatment of Pancreatic Diseases: Focus on Surgery, Electrochemotherapy and Rituximab
por: Coriat, Romain, et al.
Publicado: (2022)

Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol
por: Sarnaik, Mubashira K, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long‐Term Safety
por: Dubcenco, E, et al.
Publicado: (2017)

The Safety of Long-term Daily Usage of a Proton Pump Inhibitor: A Literature Review
por: Abbas, Mohammed K, et al.
Publicado: (2019)

Results of the national organised colorectal cancer screening program with FIT in Paris
por: Pellat, Anna, et al.
Publicado: (2018)

Levels of Evidence Supporting United States Guidelines in Pancreatic Adenocarcinoma Treatment
por: Pellat, Anna, et al.
Publicado: (2022)

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
por: Janett, Simone, et al.
Publicado: (2015)

Hypomagnesaemia associated with long-term use of proton pump inhibitors
por: Toh, James Wei Tatt, et al.
Publicado: (2015)

Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
por: Kinoshita, Yoshikazu, et al.
Publicado: (2018)

Outcomes of endoscopic mucosal resection for large superficial non-ampullary duodenal adenomas
por: Amoyel, Maxime, et al.
Publicado: (2022)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Neuroendocrine Carcinomas of the Digestive Tract: What Is New?
por: Pellat, Anna, et al.
Publicado: (2021)

A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children
por: Dipasquale, Valeria, et al.
Publicado: (2022)

Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors
por: Maideen, Naina Mohamed Pakkir
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
por: Ikemura, Kenji, et al.
Publicado: (2017)

Epidemiological Study Assessing the Overuse of Proton Pump Inhibitors in Lebanese Population
por: Hoteit, Mayssaa, et al.
Publicado: (2020)

Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases
por: Gurbel, Paul A, et al.
Publicado: (2010)

The risks of long-term use of proton pump inhibitors: a critical review
por: Jaynes, Megan, et al.
Publicado: (2018)

Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden
por: Brusselaers, Nele, et al.
Publicado: (2019)

Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper
por: Raoul, Jean-Luc, et al.
Publicado: (2022)

Proton pump inhibitors alter the composition of the gut microbiota
por: Jackson, Matthew A, et al.
Publicado: (2016)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

The Role of Magnetic Resonance Imaging in the Management of Esophageal Cancer
por: Pellat, Anna, et al.
Publicado: (2022)

Colorectal cancer screening programme: is the French faecal immunological test (FIT) threshold optimal?
por: Pellat, Anna, et al.
Publicado: (2021)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011)

Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
por: Swaminathan, Krishnan
Publicado: (2015)

Proton pump inhibitors: A balanced view
por: Ramakrishna, B.S.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ubjkn2r28qmgjnb434bm3nefjk